- Total Pro Portfolios with LDG:
- Forward Hoover Small Cap Equity (Barrons Sep 18)
- Stadia Capital
- show more
- Total Do-It-Yourself Portfolios with LDG:
- Tinas
- John's Investment Selection
- Economic Indicator - Rate Hike/Recession/Inflation
- robin
- TR-Drug Store
- Best Ideas
- calboy Portfolio 1
- chia422 Portfolio 1
- Barron's Activist Stocks 8-23-2008
- show more
- 18
- Brian Bergerson Portfolio 1
- Hard Hats Only
- Don Richmond Portfolio 1
- Dollar22 Portfolio 1
- New Wave
- chris@commtrav.com Portfolio 1
- timothywko Portfolio 1
- Barron's Activist Stocks 8-09-2008
- Barron's Activist Stocks 9-20-2008
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
By:barrons3 |
Date:09 20 08 |
Pershing Square Capital Management doesn't support the tender offer by CVS Caremark (CVS) for Longs Drug Stores. Pershing Square, which is run by activist investor William Ackman, said that the process that led to the CVS transaction was "seriously flawed," and that the value of Longs substantially exceeds the bid of $71.50 a share. Pershing Square holds about 3.1 million shares (8.7% of the total shares outstanding). It has economic exposure to about 9.2 million notional shares (25.6% stake). |
|
Not yet rated
Rate now:
|
|
By:barrons2 |
Date:08 23 08 |
Advisory Research, a Chicago fund manager, asked Longs for more information to evaluate CVS Caremark 's (CVS) tender offer. Advisory Research wants to know more about Longs' assets, specifically the valuation of real estate it owns and leases, to determine if the CVS offer is in Longs' shareholders' best interests. CVS has begun a cash tender offer for all outstanding Longs shares for $2.61 billion, or $71.50 each. Advisory Research has 3,304,287 shares (9.2%). |
|
Not yet rated
Rate now:
|
|
By:Dollar22 |
Date:09 27 07 |
West coast pharmacy, turn around story, little exposure to wal-mart |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Downgraded by Matrix Research from Buy to Hold |
|
Not yet rated
Rate now:
|
|
Date:02 06 07 |
|
In The Same Business As Rite Aid. |
|
Not yet rated
Rate now:
|
|
By:Tina |
Date:01 17 07 |
stable stock |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
| Comments not available |



